Using Vision to Study Poststroke Recovery and Test Hypotheses About Neurorehabilitation. (February 2019)

• Record Type: Journal Article
• Authors: Busza, Ania; Schneider, Colleen L.; Williams, Zoë R.; Mahon, Bradford Z.; Sahin, Bogachan
• Is Part Of: Neurorehabilitation & neural repair. Volume 33:Number 2(2019)
• Page Start: 87
• Page End: 95
• Publication Date: 2019-02
• Subjects: stroke -- stroke rehabilitation -- rehabilitation research -- cortical blindness -- vision disorders -- hemianopia; Nervous system -- Diseases -- Patients -- Rehabilitation -- Periodicals; Brain damage -- Patients -- Rehabilitation -- Periodicals; Spinal cord -- Wounds and injuries -- Patients -- Rehabilitation -- Periodicals; Nervous system -- Regeneration -- Periodicals; Neuroplasticity -- Periodicals; 616.804305
• DOI: 10.1177/1545968319827569
• Languages: English
• ISSNs: 1545-9683

Abstract

Approximately one-third of stroke patients suffer visual field impairment as a result of their strokes. However, studies using the visual pathway as a paradigm for studying poststroke recovery are limited. In this article, we propose that the visual pathway has many features that make it an excellent model system for studying poststroke neuroplasticity and assessing the efficacy of therapeutic interventions. First, the functional anatomy of the visual pathway is well characterized, which makes it well suited for functional neuroimaging studies of poststroke recovery. Second, there are multiple highly standardized and clinically available diagnostic tools and outcome measures that can be used to assess visual function in stroke patients. Finally, as a sensory modality, the assessment of vision is arguably less likely to be affected by confounding factors such as functional compensation and patient motivation. Given these advantages, and the general similarities between poststroke visual field recovery and recovery in other functional domains, future neurorehabilitation studies should consider using the visual pathway to better understand the physiology of neurorecovery and test potential therapeutics.